Profile
Dr. Akram Bouchenaki is Senior Vice President-Strategic Marketing at moksha8 Pharmaceuticals, Inc.
Dr. Bouchenaki was previously employed as Manager-Oncology Division by Bristol-Myers Squibb Co., Senior Director-Commercial Operations by Gilead Sciences, Inc., and an Product Manager by GlaxoSmithKline LLC.
He received his doctorate degree from Université Paris 1.
Former positions of Akram Bouchenaki
| Companies | Position | End |
|---|---|---|
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | - |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Moksha8 Pharmaceuticals, Inc.
Moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes medicines | Sales & Marketing | - |
Training of Akram Bouchenaki
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 5 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Moksha8 Pharmaceuticals, Inc.
Moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes medicines | Health Technology |
Université Paris 1 Panthéon-Sorbonne
Université Paris 1 Panthéon-Sorbonne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
- Stock Market
- Insiders
- Akram Bouchenaki
















